You are here

  • Home
  • Archive
  • Volume 11, Issue 6
  • Response to "NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng

Article metrics

Article menu

Download PDFPDF

Letter
Response to "NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng

 

Online download statistics by month:

Online download statistics by month: June 2023 to February 2026

AbstractFullPdf
Jun 2023015514
Jul 202309428
Aug 202309010
Sep 20230568
Oct 20230397
Nov 20230556
Dec 202304418
Jan 20240299
Feb 20240229
Mar 202402018
Apr 202401523
May 20240194
Jun 202402712
Jul 202403613
Aug 20240248
Sep 202402416
Oct 202402815
Nov 20240208
Dec 20240264
Jan 202502010
Feb 202501913
Mar 202502110
Apr 202504511
May 20250169
Jun 20250239
Jul 2025010
Feb 2026010
Total0969292